Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Big oil lifts FTSE 100 as inflation hits Europe

Tue, 31st May 2022 17:07

(Alliance News) - Stocks in London ended mixed on Tuesday with oil majors helping lift the FTSE 100, while the European counterparts grappled with record inflation.

The FTSE 100 index closed up 7.60 points, or 0.1%, at 7,607.66. The mid-cap FTSE 250 index closed down 128.94 points, or 0.6%, at 20,417.95. The AIM All-Share index closed down 0.12 of a point at 974.09.

The Cboe UK 100 index closed down 0.1% at 756.27. The Cboe 250 ended up 0.9% at 18,068.49 and the Cboe Small Companies finished 0.8% lower at 14,620.56.

In mainland Europe, the CAC 40 stock index in Paris closed down 1.4%, while the DAX 40 in Frankfurt ended down 1.3%.

"Once again stronger commodity prices, led principally by oil, have been the foundation of the FTSE 100's strength. Having suffered less during the recent volatility thanks to its raw material names, the index is now clinging to positive territory for the time being," said IG Group's Chris Beauchamp.

BP and Shell closed up 0.2% and 0.1% respectively, tracking spot oil prices higher.

Brent oil was quoted at USD123.75 a barrel at the equities close, up sharply from USD120.20 at the close Monday.

Crude prices built on Monday's advance after the EU reached a deal on a partial embargo of Russian imports as part of a punishment for its invasion of Ukraine.

Meanwhile, Saudi Arabia, Russia and their allies are likely to stick to their policy of modest oil output increases when they meet Thursday after the EU banned most imports from Moscow. This has caused oil prices, which have already hit record highs so far this year, to soar further amid pressure on the 23-member OPEC+ to open taps more widely and relieve the market.

In the FTSE 100, Unilever ended the best performer, up 9.0%, after the consumer goods firm appointed activist investor Nelson Peltz to its board, starting July 20.

Peltz is chief executive officer and a founding partner of Trian Fund Management LP. Funds managed by Trian have 37.4 million Unilever shares, a 1.5% stake, both companies confirmed.

"We are pleased to be welcoming Nelson to the Unilever board," said Unilever Chair Nils Andersen. "We have held extensive and constructive discussions with him and the Trian team and believe that Nelson's experience in the global consumer goods industry will be of value to Unilever as we continue to drive the performance of our business."

AJ Bell's Russ Mould commented: "Inviting Peltz in is only likely to ramp up the pressure on beleaguered CEO Alan Jope and we may now see the company advance plans to streamline the business and address governance concerns."

BT Group closed up 1.7% after the telecommunications provider entered a new "multi-million pound" joint venture partnership with Swedish peer Telefonaktiebolaget LM Ericsson.

BT has signed a multi-year contract with Stockholm-based Ericsson, which will enable it to sell the mobile network technology products to businesses and organisations in different sectors. These include manufacturing, defence, education, retail, healthcare, transport and logistics, it listed.

5G private networks are expected to grow at an average rate of 40% a year between 2021 and 2028, according to a forecast BT sourced from MarketResearch.com. At this time the market will be worth USD14 billion, BT continued.

GSK closed up 0.2% after the drugmaker agreed to buy Affinivax for up to USD3.3 billion, to gain access its "highly innovative" next-generation 24-valent pneumococcal vaccine candidate.

Affinivax is a Boston, Massachusetts-based clinical-stage biopharmaceutical firm focused on developing a novel class of pneumococcal vaccines.

London-based GSK said that in addition to a USD2.1 billion initial payment, it will potentially make two milestone payments of USD600 million each, dependent on the achievement of paediatric clinical development milestones.

GSK said Affinivax was attractive for its pneumococcal vaccine candidate, as well as multiple antigen presenting system, which GSK described as novel technology. The vaccine targets streptococcus pneumoniae, an anaerobic bacteria that can cause middle ear infections, sepsis in children and pneumonia in immunocompromised individuals.

Languishing at the end of the large-caps, B&M European Value Retail was the worst performer, down 14%, after the variety store chain warned over inflationary pressures. It also promoted its current chief financial officer to replace the departing Chief Executive Simon Arora.

The Luxembourg-headquartered retailer said the appointment of Alex Russo as its new chief executive officer reflected the outcome of a "thorough assessment and external benchmarking process over the last six weeks."

B&M reported flat annual profit despite a decline in revenue. For the 52 weeks ended on March 26, pretax profit was stable at GBP525 million, while revenue slipped to GBP4.67 billion from GBP4.80 billion the year prior.

Outgoing CEO Arora said: "The retail industry is facing inflationary pressures whilst our customers are having to cope with a significant increase in the cost of living, making spending behaviour in the year ahead difficult to predict. However, we have seen before that during such times customers will increasingly seek out value for money, and B&M is ideally placed to serve those needs."

B&M declared a final dividend of 11.5 pence, falling from the 13.0p final payout offered last year. The total dividend was cut to 16.5p from 17.3p.

Looking ahead, the company noted: "Notwithstanding the many and varied uncertainties and headwinds which are likely to impact on our trading performance during [the next financial year], at this early stage in the year group adjusted Ebitda is expected to be in the range of GBP550 million to GBP600 million, significantly ahead of the [financial 2020] pre-pandemic level of GBP342 million."

Adjusted Ebitda in financial 2022 came in at GBP619 million.

Royal Mail was the second-worst performer, down 5.7%, as the postal operator faces imminent demotion from the FTSE 100 with a market capitalisation of GBP2.96 billion. FTSE Russell will announce its latest index review changes on Wednesday, which will be based on Tuesday's closing prices.

In the FTSE 250, Trustpilot ended the worst performer, down 8.6%. With a market value of GBP396.3 million, the online review site is staring down the barrel of demotion from the mid-cap index.

The pound was quoted at USD1.2605 at the London equities close, down from USD1.2640 at the close Monday.

The euro stood at USD1.0722 at the European equities close, down from USD1.0780 late Monday.

The single currency was on the back foot despite data showing the eurozone's inflation rate rising to another record high in May on the fallout from Russia's invasion of Ukraine.

Eurozone consumer price inflation is expected to be 8.1% in May, accelerating from 7.4% annually in April, according to the latest flash estimate from Eurostat, the statistical office of the European Union, on Tuesday.

Red-hot eurozone inflation intensified calls for interest rate hikes from the European Central Bank, which has already flagged plans to hike borrowing costs in July.

Against the yen, the dollar was trading at JPY128.50, up from JPY127.60 late Monday.

Stocks in New York were lower at the London equities close following the long holiday weekend. The DJIA was down 0.5%, the S&P 500 index down 0.6% and the Nasdaq Composite down 0.5%.

Gold stood at USD1,845.51 an ounce at the London equities close, lower against USD1,857.80 late Monday.

The economic events calendar on Wednesday has manufacturing PMI readings from the eurozone at 0900 BST, the UK at 0930 BST and the US at 1445 BST. The Bank of Canada interest rate decision is at 1500 BST.

The UK corporate calendar on Wednesday has annual results from iconic boot maker Dr Martens and interim results from Impax Asset Management.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
Today 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.